{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T14:37:32Z","timestamp":1648910252529},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Pharmacology: The Vascular System"],"published-print":{"date-parts":[[1982,1]]},"DOI":"10.1016\/0306-3623(82)90111-2","type":"journal-article","created":{"date-parts":[[2002,12,14]],"date-time":"2002-12-14T11:00:52Z","timestamp":1039863652000},"page":"439-443","source":"Crossref","is-referenced-by-count":0,"title":["A comparison of the dose-response effects of captopril in anaesthetized normotensive and renovascular hypertensive rats"],"prefix":"10.1016","volume":"13","author":[{"given":"Joelle","family":"Baranes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Thi\u00e9vant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheline","family":"Le Hegarat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Delaflotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Clostre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis V.","family":"DeFeudis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0306-3623(82)90111-2_BIB1","series-title":"New Trends in Arterial Hypertension, INSERM Symposium No. 17","first-page":"249","article-title":"Pharmacology and mode of action of captopril","author":"Antonaccio","year":"1981"},{"key":"10.1016\/0306-3623(82)90111-2_BIB2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/10641968009037127","article-title":"Angiotensin II and renal hypertension in dog, rat and man: Effect of converting enzyme inhibition","volume":"2","author":"Atkinson","year":"1980","journal-title":"Clin. exp. Hypertension"},{"key":"10.1016\/0306-3623(82)90111-2_BIB3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/cs0570053","article-title":"Antihypertensive effect of prolonged blockade of angiotensin formation in benign and malignant, one and two-kidney Goldblatt hypertensive rats","volume":"57","author":"Bengis","year":"1979","journal-title":"Clin. Sci."},{"key":"10.1016\/0306-3623(82)90111-2_BIB4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/01.RES.29.6.654","article-title":"Role of the renin-angiotensin system in the pathogenesis of severe hypertension in rats","volume":"29","author":"Carretero","year":"1971","journal-title":"Circulation Res."},{"key":"10.1016\/0306-3623(82)90111-2_BIB5","first-page":"483","article-title":"Effects of the nonapeptide SQ 20881 on blood pressure of rats with experimental renovascular hypertension","volume":"143","author":"Engel","year":"1973"},{"key":"10.1016\/0306-3623(82)90111-2_BIB6","first-page":"561","article-title":"Experimental model of severe renal hypertension","volume":"87","author":"Fernandes","year":"1976","journal-title":"J. Lab. clin. Med."},{"key":"10.1016\/0306-3623(82)90111-2_BIB7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM197805042981803","article-title":"Antihypertensive effect of the oral angiotensin-converting enzyme inhibitor SQ 14225 in man","volume":"298","author":"Gavras","year":"1978","journal-title":"New Engl. J. Med."},{"key":"10.1016\/0306-3623(82)90111-2_BIB8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.59.3.347","article-title":"Studies on experimental hypertension","volume":"59","author":"Goldblatt","year":"1934","journal-title":"J. exp. Med."},{"key":"10.1016\/0306-3623(82)90111-2_BIB9","first-page":"131","article-title":"Characteristics of arterial plasma membrane in renovascular hypertension in rats","volume":"17","author":"Kwan","year":"1980","journal-title":"Blood Vessels"},{"key":"10.1016\/0306-3623(82)90111-2_BIB10","first-page":"281","article-title":"Antihypertensive activity in rats of SQ 14225, an orally active inhibitor of angiotensin I-converting enzyme","volume":"204","author":"Laffan","year":"1977","journal-title":"J. Pharmac. exp. Ther."},{"key":"10.1016\/0306-3623(82)90111-2_BIB11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(80)90013-8","article-title":"Effect of the time interval between blood sampling and assay on angiotensin I-converting enzyme activity from captopril-treated rats","volume":"67","author":"Lai","year":"1980","journal-title":"Eur. J. Pharmac."},{"key":"10.1016\/0306-3623(82)90111-2_BIB12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/cs0580001","article-title":"Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): The role of factors other than renin-angiotensin blockade in the rat","volume":"58","author":"Marks","year":"1980","journal-title":"Clin. Sci."},{"key":"10.1016\/0306-3623(82)90111-2_BIB13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","article-title":"Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents","volume":"196","author":"Ondetti","year":"1977","journal-title":"Science"},{"key":"10.1016\/0306-3623(82)90111-2_BIB14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(78)90429-6","article-title":"Chronic antihypertensive effects of captopril (SQ 14 225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats","volume":"51","author":"Rubin","year":"1978","journal-title":"Eur. J. Pharmac."},{"key":"10.1016\/0306-3623(82)90111-2_BIB15","series-title":"The Squibb Institute for Preclinical Research","year":"1979"},{"key":"10.1016\/0306-3623(82)90111-2_BIB16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-8703(40)90192-2","article-title":"The production of a pressor substance by the totally ischemic kidney","volume":"19","author":"Taquini","year":"1940","journal-title":"Am. Heart J."},{"key":"10.1016\/0306-3623(82)90111-2_BIB17","first-page":"4813","article-title":"Inhibiteurs des enzymes de conversion et traitement de l'hypertension art\u00e9rielle","volume":"87","author":"Tcherdakoff","year":"1980","journal-title":"Gaz. M\u00e9d. Fr."}],"container-title":["General Pharmacology: The Vascular System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0306362382901112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0306362382901112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T12:56:39Z","timestamp":1554123399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0306362382901112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,1]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1982,1]]}},"alternative-id":["0306362382901112"],"URL":"https:\/\/doi.org\/10.1016\/0306-3623(82)90111-2","relation":{},"ISSN":["0306-3623"],"issn-type":[{"value":"0306-3623","type":"print"}],"subject":[],"published":{"date-parts":[[1982,1]]}}}